Ekso Bionics Stock (NASDAQ:EKSO)
Previous Close
$17.64
52W Range
$2.73 - $26.56
50D Avg
$10.62
200D Avg
$6.93
Market Cap
$38.57M
Avg Vol (3M)
$78.94K
Beta
0.82
Div Yield
-
EKSO Company Profile
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.